Financial Information of Dr. Agarwal's Health Care Limited IPO
The Revenues from operations for the period ended on Sep 30, 2024, Fiscals ended 2024, 2023 and 2022 were ₹ 8,379.40 Million, ₹ 13,764.49 Million, ₹ 10,314.94 Million and ₹ 7,137.84 Million respectively. The EBITDA for the period ended on Sep 30, 2024, Fiscals ended 2024, 2023 and 2022 were ₹ 2,284.77 Million, ₹ 4,065.55 Million, ₹ 2,838.60 Million, and ₹ 1,998.22 Million, respectively. The Profit after Tax for the period ended on Sep 30, 2024, Fiscals ended 2024, 2023 and 2022 were ₹ 395.64 Million, ₹ 950.51 Million, ₹ 1,032.30 Million, and ₹ 431.64 Million respectively. This indicates a steady growth in financial performance.
| Period Ended | Sep 30, 2024 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
|---|---|---|---|---|
| Reserve of Surplus | 14,736.35 | 13,300.48 | 6,216.31 | 2,055.17 |
| Total Assets | 33,934.07 | 26,221.01 | 18,251.74 | 10,261.34 |
| Total Borrowings | 3,692.80 | 3,877.87 | 3,561.77 | 2,901.80 |
| Fixed Assets | 5,902.60 | 4,984.68 | 3,429.46 | 2,081.88 |
| Cash | 1,667.60 | 1,117.49 | 1,269.81 | 996.21 |
| Net Borrowing | 2,025.20 | 2,760.38 | 2,291.96 | 1,905.59 |
| Revenue | 8,379.40 | 13,764.49 | 10,314.94 | 7,137.84 |
| EBITDA | 2,284.77 | 4,065.55 | 2,838.60 | 1,998.22 |
| PAT | 395.64 | 950.51 | 1,032.30 | 431.64 |
| EPS | 1.00 | 3.13 | 4 | 1.83 |
Note 1:- RoE, ROCE & RoNW calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit/Loss for the Year) on 31st Mar, 2024 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on Cap Price Post Offer, given in FINANCIAL EXPRESS.
Copyright @2020 Design & Developed by Info Web Software